Assessment of Research Digest Impact for Minority With Prostate Cancer, MiCAP Phase III Study

Prostate Carcinoma Clinical Trial

— MiCaP  

Official title:

Minority Prostate Cancer (MiCaP) Phase III (Aim 3): Assessment of Research Digest Impact

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05895279
• Other study ID #: 21-006715
• Secondary ID: NCI-2022-0990621
• Status: Completed
• Phase: N/A
• Start date: August 2, 2021
• Est. completion date: September 30, 2021

Study information

• Verified date: May 2024
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This phase III trial determines how well the Minority Prostate Cancer (MiCaP) Research Digest works in providing information to black men about the latest prostate cancer research. MiCaP Research Digest may be an effective method to help people learn about prostate cancer.This goal of this trial is to create educational programming that helps Black men make informed decisions about their prostate healthcare since Black men are diagnosed with prostate cancer more than any other race or ethnicity.

Description:

PRIMARY OBJECTIVE: I. To develop a research dissemination program, the Minority Prostate Cancer (MiCaP) Research Digest, which will spread information about CaP scientific discoveries, evidence-based interventions, and open clinical trials instantly among black males (BM). OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants watch MiCaP Research Digest video on study. Participants complete a survey throughout the trial. ARM II: Participants watch an alternative video on study. Participants complete a survey throughout the trial.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 220
• Est. completion date: September 30, 2021
• Est. primary completion date: September 30, 2021
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 35 Years to 70 Years

Eligibility

Inclusion Criteria:

• Identify as a Black male
• Between the ages of 35 and 70
• For virtual data collection, have access to the internet and Zoom (if joining study online)
• For virtual data collection, reside anywhere in the U.S.
• For in-person data collection, reside in one of the nine (9) catchment areas of the Mayo Clinic Cancer Center: Baker, Duval, Nassau, Clay, St. John's, Putnam, Flagler, Volusia and Brevard

Exclusion Criteria:

• Identify as a race or ethnicity that is not Black
• Identify as female
• Be younger than age 35 and older than age 70
• Lack access to internet and Zoom (if joining study online)

Related Conditions & MeSH terms

• Prostate Carcinoma
• Prostatic Neoplasms

Intervention

Other:
• Media Intervention
Watch MiCaP Research Digest video
• Media Intervention
Watch alternate video
• Survey Administration
Complete survey

Locations

Country	Name	City	State
United States	Mayo Clinic in Florida	Jacksonville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in perception of access to medical services and general health	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding access to medical services and general health with a yes/no response.	Baseline, 1 hour after video intervention
Primary	Change in perception in participation with clinical trials about prostate cancer	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 10 questions regarding views on participating in clinical trials about prostate cancer with a yes/no response.	Baseline, 1 hour after video intervention
Primary	Change in perception of familiarity with prostate cancer research	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding views on participating in clinical trials about prostate cancer with a true/false/don't know response.	Baseline, 1 hour after video intervention
Primary	Change in perception of familiarity with a research study protocol	Using the Minority Prostate Cancer (MiCaP) survey developed for this study, participants are asked 5 questions regarding information about a study protocol with a true/false/don't know response.	Baseline, 1 hour after video intervention

External Links

•   Mayo Clinic Clinical Trials